Endonovo Therapeutics Inc (ENDV)

[Craig305]

Since you mentioned uplisting, let's expand on the possibility.
Do you (or anyone here) think positive pre-clinical results would be enough to catapult the SP high enough?
Or do you think it will take FDA approval to get us uplisted. This is with the assumption of no reverse split.

You have mentioned FDA fast track in the past. What does that mean time-wise?
Getting FDA to start their trial immediately? Eliminating geting in line behind other company clinicals?
How much time are we looking at in a FDA trial (once the testing starts)?

Once they are in the FDA trial stage, will this be significantly more expensive for ENDV? Hopefully the SP will be higher so the dilution will not max out the O/S to the A/S.